PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity-Reference-Cited by-同舟云学术

PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity

Published:2023-09 Issue:9 Volume:31 Page:2633-2650
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sun Xiaoya,Bai Chenjun,Li Haozheng,Xie Dafei,Chen Shi,Han Yang,Luo Jinhua,Li Yang,Ye Yumeng,Jia Jin,Huang Xin,Guan Hua,Long Dingxin,Huang Ruixue,Gao Shanshan,Zhou Ping-Kun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference69 articles.

1. Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways;Cole;Cell. Mol. Life Sci.,2021

2. Structure and Function of Chromatin Remodellers;Reyes;J. Mol. Biol.,2021

3. Poly(ADP-ribose) polymerase inhibition: past, present and future;Curtin;Nat. Rev. Drug Discov.,2020

4. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy;Huang;Signal Transduct. Target. Ther.,2021

5. Multiple roles for PARP1 in ALC1-dependent nucleosome remodelling;Ooi;Proc. Natl. Acad. Sci. USA,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of N6‐methyladenosine RNA modification in cancer;MedComm;2024-09

2. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer;Molecular Cancer;2024-07-05

3. The Emerging Role of LPA as an Oncometabolite;Cells;2024-04-04

4. RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy;International Journal of Molecular Sciences;2024-02-23

5. Moving the Needle Forward in Genomically-Guided Precision Radiation Treatment;Cancers;2023-11-07